The impact of transcatheter edge-to-edge repair on mitral valve annular geometry.


Journal

Current opinion in cardiology
ISSN: 1531-7080
Titre abrégé: Curr Opin Cardiol
Pays: United States
ID NLM: 8608087

Informations de publication

Date de publication:
01 Mar 2022
Historique:
pubmed: 22 1 2022
medline: 30 4 2022
entrez: 21 1 2022
Statut: ppublish

Résumé

Mitral valve transcatheter edge-to-edge repair (TEER) is becoming increasingly common to treat severe mitral regurgitation. However, the lack of concomitant annuloplasty raises concerns regarding its durability. As a result, there is an emerging body of literature evaluating the impacts of TEER on mitral annular geometry. In this review, we summarize the most recent literature evaluating the impacts of TEER on annular geometry in the acute, intermediate and long-term. We also review the relationship between changes in annular geometry and clinical endpoints. Current evidence suggests that TEER acutely induces favourable changes in mitral annular size and shape, which may persist for at least up to 1 year. Few studies suggest that TEER-induced annular remodelling is associated with positive clinical outcomes. The current body of literature is sparse and limited to primarily small case series. Data from the surgical literature suggest that ringless edge-to-edge repair is associated with eventual failure. Unfortunately, few studies evaluate TEER-induced annular changes beyond the acute postprocedural phase. Future research needs to focus on and evaluate the significance of TEER-induced changes in annular dimensions in the long-term.

Identifiants

pubmed: 35058414
doi: 10.1097/HCO.0000000000000950
pii: 00001573-202203000-00003
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

150-155

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Références

Elbadawi A, Elgendy IY, Mohamed AH, et al. Temporal trends and outcomes of transcatheter mitral valve repair and surgical mitral valve intervention. Cardiovasc Revasc Med 2020; 21:1560–1566.
Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011; 364:1395–1406.
Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 2018; 379:2307–2318.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143:e72–227.
Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001; 122:674–681.
Maisano F, Torracca L, Oppizzi M, et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg 1998; 13:240–245. discussion 245–246.
Maisano F, Caldarola A, Blasio A, et al. Midterm results of edge-to-edge mitral valve repair without annuloplasty. J Thorac Cardiovasc Surg 2003; 126:1987–1997.
Gillinov AM, Tantiwongkosri K, Blackstone EH, et al. Is prosthetic anuloplasty necessary for durable mitral valve repair? Ann Thorac Surg 2009; 88:76–82.
De Bonis M, Lapenna E, Pozzoli A, et al. Edge-to-edge surgical mitral valve repair in the era of MitraClip: what if the annuloplasty ring is missed? Curr Opin Cardiol 2015; 30:155–160.
Tabata N, Weber M, Sugiura A, et al. Impact of the leaflet-to-annulus index on residual mitral regurgitation in patients undergoing edge-to-edge mitral repair. JACC Cardiovasc Interv 2019; 12:2462–2472.
Perloff JK, Roberts WC. The mitral apparatus. Circulation 1972; 46:227–239.
Latib A, Ancona MB, Ferri L, et al. Percutaneous direct annuloplasty with Cardioband to treat recurrent mitral regurgitation after MitraClip implantation. JACC Cardiovasc Interv 2016; 9:e191–e192.
Edwards Lifesciences. The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study [Internet]. clinicaltrials.gov; 2020 Sep [cited 17 August 2021]. Report No.: NCT03170349. https://clinicaltrials.gov/ct2/show/NCT03170349 . [Accessed 17 August 2021]
Webb JG, Hensey M, Szerlip M, et al. 1-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study. JACC Cardiovasc Interv 2020; 13:2344–2357.
Herrmann HC, Maisano F. Transcatheter therapy of mitral regurgitation. Circulation 2014; 130:1712–1722.
Chen M, Sun L. What is the next generation of transcatheter mitral valve repair devices? Front Cardiovasc Med 2021; 8:48.
Silvestry FE, Rodriguez LL, Herrmann HC, et al. Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVEREST I. J Am Soc Echocardiogr 2007; 20:1131–1140.
Bhudia SK, McCarthy PM, Smedira NG, et al. Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings. Ann Thorac Surg 2004; 77:1598–1606.
Hirji SA, Del Val FR, Yazdchi F, et al. Mitral valve repair using edge-to-edge technique in various situations: real-world experiences. Eur J Cardiothorac Surg 2019; 56:1110–1116.
Mack MJ, Lindenfeld J, Abraham WT, et al. 3-year outcomes of transcatheter mitral valve repair in patients with heart failure. J Am Coll Cardiol 2021; 77:1029–1040.
Schmidt FP, von Bardeleben RS, Nikolai P, et al. Immediate effect of the MitraClip® procedure on mitral ring geometry in primary and secondary mitral regurgitation. Eur Heart J Cardiovasc Imaging 2013; 14:851–857.
Hidalgo F, Mesa D, Ruiz M, et al. Effects of mitral annulus remodeling following MitraClip procedure on reduction of functional mitral regurgitation. Rev Esp Cardiol (Engl Ed) 2016; 69:1020–1025.
Noack T, Kiefer P, Mallon L, et al. Changes in dynamic mitral valve geometry during percutaneous edge–edge mitral valve repair with the MitraClip system. J Echocardiogr 2019; 17:84–94.
Donmez E, Salcedo EE, Quaife RA, et al. The acute effects of edge-to-edge percutaneous mitral valve repair on the shape and size of the mitral annulus and its relation to mitral regurgitation. Echocardiography 2019; 36:732–741.
Kim J, Palumbo MC, Khalique OK, et al. Transcatheter MitraClip repair alters mitral annular geometry – device induced annular remodeling on three-dimensional echocardiography predicts therapeutic response. Cardiovascular Ultrasound 2019; 17:31.
Caballero A, Mao W, McKay R, et al. A comprehensive engineering analysis of left heart dynamics after MitraClip in a functional mitral regurgitation patient. Front Physiol 2020; 11:432.
Patzelt J, Zhang Y, Magunia H, et al. Improved mitral valve coaptation and reduced mitral valve annular size after percutaneous mitral valve repair (PMVR) using the MitraClip system. Eur Heart J Cardiovasc Imaging 2018; 19:785–791.
Trasca L, Sanchis L, Regueiro A, et al. Changes in mitral valve geometry after percutaneous valve repair with the MitraClip® System. Int J Cardiovasc Imaging 2021; 37:1577–1585.
Schueler R, Kaplan S, Melzer C, et al. Impact of interventional edge-to-edge repair on mitral valve geometry. Int J Cardiol 2017; 230:468–475.
Schueler R, Momcilovic D, Weber M, et al. Acute changes of mitral valve geometry during interventional edge-to-edge repair with the MitraClip system are associated with midterm outcomes in patients with functional valve disease. Circ Cardiovasc Interv 2014; 7:390–399.
Cimino S, Maestrini V, Cantisani D, et al. Mid-term repair durability after MitraClip implantation in patients with functional mitral regurgitation. J Cardiovasc Med 2019; 20:701–708.
Messika-Zeitoun D, Nickenig G, Latib A, et al. Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes. Eur Heart J 2019; 40:466–472.
Rogers JH, Boyd WD, Smith TW, Bolling SF. Early experience with Millipede IRIS transcatheter mitral annuloplasty. Ann Cardiothorac Surg 2018; 7:780–786.

Auteurs

Adam Eqbal (A)

Division of Cardiac Surgery, Department of Surgery, McMaster University, Hamilton.

Saurabh Gupta (S)

Division of Cardiac Surgery, Department of Surgery, McMaster University, Hamilton.

Neil Fam (N)

Structural Heart Program, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.

Géraldine Ong (G)

Structural Heart Program, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.

Gianluigi Bisleri (G)

Structural Heart Program, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH